# EDGAR Filing Document

**Accession Number:** 0001684144
**File Stem:** 0001654954-25-006676
**Filing Date:** 2025-6
**Character Count:** 5669
**Document Hash:** d658bfe28b1f2d5a5b5e7d18163f83cd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-006676.hdr.sgml**: 20250606

**ACCESSION NUMBER**: 0001654954-25-006676

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250606

**DATE AS OF CHANGE**: 20250606

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zomedica Corp.
- **CENTRAL INDEX KEY:** 0001684144
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38298
- **FILM NUMBER:** 251029944

**BUSINESS ADDRESS:**
- **STREET 1:** 100 PHOENIX DRIVE
- **STREET 2:** SUITE 125
- **CITY:** ANN ARBOR
- **STATE:** MI
- **ZIP:** 48108
- **BUSINESS PHONE:** (734) 369-2555

**MAIL ADDRESS:**
- **STREET 1:** 100 PHOENIX DRIVE
- **STREET 2:** SUITE 125
- **CITY:** ANN ARBOR
- **STATE:** MI
- **ZIP:** 48108

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Zomedica Pharmaceuticals Corp.
- **DATE OF NAME CHANGE:** 20160908

**United States**

**Securities and Exchange Commission**

**Washington, D.C. 20549**

**SCHEDULE 14A**

**Proxy Statement Pursuant to Section 14(a) of the**

**Securities Exchange Act of 1934**

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Materials under § 240.14a-12

---

| |
|:---|
| **ZOMEDICA CORP.** |
| **(Name of Registrant as Specified in Its Charter)** |

---

_________________________________________________________

**(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)**

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

On May 29, 2025, Zomedica Corp. sent the following message to its shareholders registered with Say Technologies, LLC ("**Say**") via Say's shareholder communication platform relating to its 2025 Annual Meeting of Shareholders:

![](zom_defa14aimg3.jpg)

Dear Shareholder:

**This Is Your Moment — Don't Miss the Chance to Be Heard**

Time is almost up. If you've been waiting to vote, this is your **last opportunity** to make it count. Proxy votes must be submitted by **June 8 at 11:59 p.m. EDT**—after that, the window closes, and your chance to help shape the company's future will be gone.

The **Annual Shareholder Meeting** is happening **virtually on June 10 at 11:00 a.m. EDT**, and while the conversation will continue, your ability to impact the outcome ends in just a few days. As a retail investor, your voice is powerful. You've invested your money—and now we're asking you to invest one more thing: your time.

**If you believe in where we're going, this is your chance to back it up with action. Review the materials. Hit the VOTE button. And be counted.**

There's still time—but not much. Let's move forward together.

<br> **Vote now** <br>

---

| | |
|:---|:---|
| ![](zom_defa14aimg4.jpg) | **Larry Heaton**<br>Chief Executive Officer, Zomedica |
| Don't want to receive shareholder messages from Zomedica? <u>Opt out</u> | Don't want to receive shareholder messages from Zomedica? <u>Opt out</u> |
| Say Technologies LLC is a third party provider of shareholder engagement services to and on behalf of public companies. This message and its contents (collectively, this "Content") is sent by the aforementioned issuer and provided for informational purposes only. This Content is not intended to provide financial, legal, tax or investment advice or recommendations. You are receiving this Content because you are a shareholder of the aforementioned issuer. This Content may contain insights and/or opinions that do not reflect the views of Say Technologies LLC or any of its subsidiaries or affiliates. Say Technologies LLC makes no representations or warranties as to the suitability, accuracy, completeness, or timeliness of the Content provided, including any information provided by third parties. This is an automated message. If you want to contact us, please do not reply to this message but instead <u>send Say support a message here</u>. Replies to this message will not be read or responded to. Read here for more information on our <u>Privacy Policy</u>. | Say Technologies LLC is a third party provider of shareholder engagement services to and on behalf of public companies. This message and its contents (collectively, this "Content") is sent by the aforementioned issuer and provided for informational purposes only. This Content is not intended to provide financial, legal, tax or investment advice or recommendations. You are receiving this Content because you are a shareholder of the aforementioned issuer. This Content may contain insights and/or opinions that do not reflect the views of Say Technologies LLC or any of its subsidiaries or affiliates. Say Technologies LLC makes no representations or warranties as to the suitability, accuracy, completeness, or timeliness of the Content provided, including any information provided by third parties. This is an automated message. If you want to contact us, please do not reply to this message but instead <u>send Say support a message here</u>. Replies to this message will not be read or responded to. Read here for more information on our <u>Privacy Policy</u>. |

---